Journal of Neuroscience, Vol 8, 3135-3143, Copyright © 1988 by Society for Neuroscience
Rat astroglial somatomedin/insulin-like growth factor binding proteins: characterization and evidence of biologic function
VK Han, JM Lauder and AJ D'Ercole
Department of Pediatrics, School of Medicine, University of North Carolina, Chapel Hill 27514.
Specific binding proteins (BPs) to somatomedin/insulin-like growth factors
(Sm/IGFs) have been identified in conditioned media from a variety of cells
in culture. By affinity cross-linking using disuccinimidyl suberate, we
have covalently cross-linked radiolabeled somatomedin-C/insulin-like growth
factor I (Sm-C/IGF I), insulin-like growth factor II (IGF II) and insulin
to BPs in conditioned medium (CM) from cultured astroglial cells derived
from cerebral cortices of neonatal rats. Two species of radiolabeled Sm/IGF
BP complexes of 40,000 Da (40K) and 45K were identified. Competition with
unlabeled Sm- C/IGF I and IGF II demonstrated that the BPs in each complex
have similar affinities for Sm-C/IGF I and IGF II. The BP in the 45K
complex was about 5-fold more sensitive to competition with unlabeled
Sm/IGFs than the BP in the 40K complex, suggesting that it either has a
higher affinity for Sm/IGFs or is less abundant. Evidence that the BPs in
each complex are distinct includes the following findings: (1) insulin
competed with Sm/IGF for binding to the 45K complex, but not the 40K
complex, and (2) the BP in the 40K complex, but not the 45K complex, was
recognized by antibodies raised against a BP purified from CM of buffalo
rat liver (BRL) 3A cells. Growth hormone did not affect the apparent
secretion of either BP. The binding activity of both BPs was retained after
mild heat treatment, changes to extremes of pH (2-10), and prolonged
storage at -20 degrees C, but was destroyed after heating to higher
temperatures (80 degrees C and greater), reduction, and proteolytic
treatment.(ABSTRACT TRUNCATED AT 250 WORDS)